Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Nicoletti

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Definitive results of a phase II trial of cisplatin, epirubicin, continuous-infusion fluorouracil, and gemcitabine in stage IV pancreatic adenocarcinomaM Reni, P Passoni, M G Panucci, et al.
Texas Heart Institute Journal|February 24, 2001
Endovascular treatment of a noninfected anastomotic juxtarenal aortic aneurysmG Melissano, C Di Mario, Y Tshomba, et al.
Neuroimage|July 27, 2001
Explicit and incidental facial expression processing: an fMRI studyM L Gorno-Tempini, S Pradelli, M Serafini, et al.
Natural Product Research|March 11, 2017
Secondary metabolites from the endophytic fungus Talaromyces pinophilusF Vinale, R Nicoletti, F Lacatena, et al.
American Journal of Clinical Oncology|April 9, 2008
PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen as second-line therapy in patients with progressive or recurrent pancreatic cancer after gemcitabine-containing chemotherapyM Reni, S Cereda, E Mazza, et al.
Wiener Klinische Wochenschrift|January 1, 1995
[A new concept in imaging pelvic recurrence of curatively operated rectal carcinoma--image fusion of nuclear magnetic resonance tomography and anti-CEA immunoscintigraphy (SPECT): technique and clinical example]L Kronberger, G F Fueger, R Nicoletti, et al.
Cancer Investigation|September 14, 2007
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: a dose-finding studyM Reni, S Cereda, E Bonetto, et al.
Cancer Investigation|December 8, 2004
Salvage chemotherapy with mitomycin, docetaxel, and irinotecan (MDI regimen) in metastatic pancreatic adenocarcinoma: a phase I and II trialMichele Reni, M G Panucci, P Passoni, et al.
Cancer Chemotherapy and Pharmacology|June 30, 2006
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinomaM Reni, S Cereda, E Bonetto, et al.
The Journal of Physiology|February 4, 2003
Ketamine increases human motor cortex excitability to transcranial magnetic stimulationV Di Lazzaro, A Oliviero, P Profice, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Definitive results of a phase II trial of cisplatin, epirubicin, continuous-infusion fluorouracil, and gemcitabine in stage IV pancreatic adenocarcinomaM Reni, P Passoni, M G Panucci, et al.
Texas Heart Institute Journal|February 24, 2001
Endovascular treatment of a noninfected anastomotic juxtarenal aortic aneurysmG Melissano, C Di Mario, Y Tshomba, et al.
Neuroimage|July 27, 2001
Explicit and incidental facial expression processing: an fMRI studyM L Gorno-Tempini, S Pradelli, M Serafini, et al.
Natural Product Research|March 11, 2017
Secondary metabolites from the endophytic fungus Talaromyces pinophilusF Vinale, R Nicoletti, F Lacatena, et al.
American Journal of Clinical Oncology|April 9, 2008
PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen as second-line therapy in patients with progressive or recurrent pancreatic cancer after gemcitabine-containing chemotherapyM Reni, S Cereda, E Mazza, et al.
Wiener Klinische Wochenschrift|January 1, 1995
[A new concept in imaging pelvic recurrence of curatively operated rectal carcinoma--image fusion of nuclear magnetic resonance tomography and anti-CEA immunoscintigraphy (SPECT): technique and clinical example]L Kronberger, G F Fueger, R Nicoletti, et al.
Cancer Investigation|September 14, 2007
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma: a dose-finding studyM Reni, S Cereda, E Bonetto, et al.
Cancer Investigation|December 8, 2004
Salvage chemotherapy with mitomycin, docetaxel, and irinotecan (MDI regimen) in metastatic pancreatic adenocarcinoma: a phase I and II trialMichele Reni, M G Panucci, P Passoni, et al.
Cancer Chemotherapy and Pharmacology|June 30, 2006
Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinomaM Reni, S Cereda, E Bonetto, et al.
The Journal of Physiology|February 4, 2003
Ketamine increases human motor cortex excitability to transcranial magnetic stimulationV Di Lazzaro, A Oliviero, P Profice, et al.
Pageof 10